diethyl-l3-silyl N-(diethyl-l3-silyl)-2,2,2-trifluoroacetimidate

Catalog No. :
ACGWWD138
CAS No. :
105384-38-1
Molecular Formula :
C10H20F3NOSi2
Molecular Weight :
283.44

IUPAC Name:diethyl-l3-silyl N-(diethyl-l3-silyl)-2,2,2-trifluoroacetimidate

diethyl-l3-silyl N-(diethyl-l3-silyl)-2,2,2-trifluoroacetimidate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namediethyl-l3-silyl N-(diethyl-l3-silyl)-2,2,2-trifluoroacetimidate
IUPAC Namediethyl-l3-silyl N-(diethyl-l3-silyl)-2,2,2-trifluoroacetimidate
Molecular FormulaC10H20F3NOSi2
Molecular Weight283.44
SMILESCC[Si](CC)N=C(O[Si](CC)CC)C(F)(F)F
InChI KeyAERQTNAPNFAWTR-UHFFFAOYSA-N
SynonymN-(Diethylsilyl)-2,2,2-trifluoroethanimidic acid diethylsilyl ester;Diethylsilyl N-(diethylsilyl)-2,2,2-trifluoroethanimidate, N,O-Bis(diethylsilyl)trifluoroacetamide;Diethylsilyl N-(diethylsilyl)trifluoroacetimidate;N,O-Bis(diethylhydrogensilyl)trifluoroacetamide [Simultaneous cyclic silylene and silyl derivatizing reagent for GC];diethylsilyl N-diethylsilyl-2,2,2-trifluoroethanimidate;N,O-BIS(DIETHYLHYDROGENSILYL)TRIFLUOROACETAMIDE;bisdiethylhydrogensilyltrifluoroacetamide;DEHS-BSTFA
CAS No.105384-38-1

Synthetic Route by SureRoute

1. ACGWWD138 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGWWD138 route product structure diagram
    ACGWWD138105384-38-1
Inquiry

2. ACGWWD138 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGWWD138 route product structure diagram
    ACGWWD138105384-38-1
Inquiry

Comments (0)